Anavex Life Sciences
AVXL
$3.44
Share price
1.47%
Change (1 day)
-57.74%
Change (1 year)
Categories
Anavex Life Sciences (AVXL) - Total assets
Total assets on the balance sheet as of December 2023 : $0.14 B
According to Anavex Life Sciences 's latest financial reports the company's total assets are $0.14 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Anavex Life Sciences - Total assets on balance sheet (from 2005 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-09-30 | $0.15 B | 1.1% |
| 2022-09-30 | $0.15 B | -5.51% |
| 2021-09-30 | $0.16 B | 367.88% |
| 2020-09-30 | $34.54 M | 36.37% |
| 2019-09-30 | $25.32 M | -3.35% |
| 2018-09-30 | $26.2 M | -5.86% |
| 2017-09-30 | $27.83 M | 193.08% |
| 2016-09-30 | $9.49 M | -38.6% |
| 2015-09-30 | $15.46 M | 110.37% |
| 2014-09-30 | $7.35 M | 1768.98% |
| 2013-09-30 | $0.39 M | 2891.33% |
| 2012-09-30 | $0.01 M | -93.52% |
| 2011-09-30 | $0.2 M | -38.44% |
| 2010-09-30 | $0.32 M | -19.28% |
| 2009-09-30 | $0.4 M | 5560.66% |
| 2008-09-30 | $0 M | 28776% |
| 2007-09-30 | $0 M | -99.8% |
| 2006-09-30 | $0.01 M | 1178.92% |
| 2005-09-30 | $0 M | -96.52% |
| 2004-09-30 | $0.02 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | $0.78 B | 431.65% | 🇺🇸 USA |
 Corcept Therapeutics
CORT | $0.62 B | 319.75% | 🇺🇸 USA |
 Palatin Technologies PTN | $13.55 M | -90.85% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.51 B | 249.13% | 🇺🇸 USA |